Pfizer

FDA Adds Heart Risk Warning to Pfizer Antibiotic

The agency is adding new warnings to the label of Zithromax, an antibiotic used to treat infections such as bronchitis and pneumonia.

The Food and Drug Administration is warning doctors and patients that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients.

The agency is adding new warnings to the label of Zithromax, which is commonly used to treat bronchitis, pneumonia and other infections.

Doctors should consider prescribing other antibiotics to patients at risk of heart problems, including those with irregular heartbeats or low levels of potassium or magnesium in their blood.

No votes yet

Pfizer: Experimental Breast Cancer Treatment Shows Promise

The pharma firm reports that the treatment has show effectiveness in slowing the progression of advanced breast cancer.

Pfizer Inc. said Wednesday that an experimental breast cancer drug it is developing was more effective than an older therapy at slowing the progression of advanced breast cancer.

Your rating: None Average: 5 (1 vote)

Pfizer Acquires NextWave Pharmaceuticals

The acquisition includes North American commercialization rights to recently approved Quillivant XR, an ADHD treatment.

Pfizer Inc. today announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD).

No votes yet

Pfizer Acquires NextWave Pharmaceuticals

The acquisition includes North American commercialization rights to recently approved Quillivant XR, an ADHD treatment.

Pfizer Inc. today announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD).

No votes yet

Bristol-Myers Squibb, Pfizer Gain Approval on Treatment for Stroke, Systemic Embolism

The anticoagulant from Bristol-Myers Squibb and Pfizer have attained approval for the drug in adult patients with nonvalvular atrial fibrillation.

Bristol-Myers Squibb and Pfizer announced today that the European Commission has approved ELIQUIS® (apixaban) for prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors. ELIQUIS is the only oral anticoagulant that has demonstrated superior risk reduction versus warfarin in the three important outcomes of stroke and systemic embolism, major bleeding, and all-cause mortality. ELIQUIS is an oral direct Factor Xa inhibitor, part of a novel therapeutic class.

No votes yet

Pfizer Launches Compact Inoculator for Vaccine Manufacturers

The Embrex vaccine manual inovoject is aimed at vaccine manufacturers and research institutions.

Pfizer Animal Health Global Poultry has launched a new, compact in ovo device aimed at vaccine manufacturers and research institutes.

No votes yet

Mylan Specialty, Pfizer Partner on Japanese Distribution of EpiPen

Pfizer will obtain the right to market and sell the epinephrine injection pen in Japan.

Mylan Specialty L.P., a subsidiary of Mylan Inc., and Pfizer Inc. today announced a license agreement, under which Pfizer will obtain the exclusive rights to market and sell EpiPen Injection 0.3/0.15mg in Japan. These products, known in the U.S. as EpiPen (epinephrine) 0.3mg and EpiPen Jr (epinephrine) 0.15mg Auto-Injectors, are for self-administration for the emergency treatment of life-threatening allergic reactions (anaphylaxis) caused by allergens, exercise or unknown triggers. EpiPen Injection is the only approved epinephrine auto-injector in Japan.

No votes yet

Viagra, Cialis Top Poll of Trusted Drug Brands

A recent poll indicates the two ED treatments are among the most-trusted brands in prescription drugs.

According to the inaugural Harris Poll Physician Pulse study of American physicians' prescribing behaviors and influences, Viagra and Cialis are the top-ranked pharmaceutical treatments in terms of trust. In fact, the three erectile dysfunction (ED) brands, also including Levitra, received some of the highest scores across all of the following categories surveyed: Anti-depressants (ADP); Anti-psychotics (APS); Erectile Dysfunction (ED); and Non-insulin Diabetes Treatments (NID).    
 

No votes yet

Pfizer Issues Recall for Lo/Ovral-28 and Norgestrel/Ethinyl Estradiol Tablets

The company has voluntarily recalled 14 lots of the drugs after determining some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence.

NEW YORK, N.Y. – Pfizer Inc. announced today that it has voluntarily recalled 14 lots of Lo/Ovral-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic) for customers in the U.S. market. An investigation by Pfizer found that some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence.

No votes yet